Form D · Pharmaceuticals
Macrotope, Inc.
Princeton, NJ · CIK 0001913044
Offering snapshot reported May 30, 2025 · SEC filing
- Reported sold
- $400K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 30, 2025 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Aug 18, 2023 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jun 3, 2022 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-547694
Source: Form D, filed May 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Anderson | Director, Executive |
| Elliot Campbell | Director, Executive |
| Elliot Camptbell | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
158 Springdale Road
Princeton, NJ, 08540
Phone: 609-915-4246
Princeton, NJ, 08540
Phone: 609-915-4246